FDA Grants Orphan Drug Designation to IH Drug Contender
A phase 3 trial is underway to evaluate the drug’s efficacy and safety in adults with IH, with enrollment expected to complete by the end of 2025.
Read More
Author: Sleep Review Staff
Advancing the Future of Sleep Medicine
An Interview with Vyto Kab, CEO, Persante Health Care
Read More
New Home Sleep Testing Service—With AI Integrations—Launches at SLEEP
The enhanced platform integrates FDA-cleared tools like BodySleep, ventilatory burden, hypoxic burden, and OSA endotyping to support personalized care.
Read More
Sleep Research Society Unveils 2025 Award Winners
The SRS has selected four sleep and circadian scientists as recipients of the 2025 Sleep Research Society awards, which recognize excellence in sleep and circadian research.
Read More
Peripheral Arterial Tonometry Is Not an Oximeter: The Real Science and Application of Peripheral Arterial Tone Signal
This on-demand webinar helps attendees examine differences between peripheral arterial tone-based devices and summarizes steps for verifying or editing automated results.
Read More